Serum Uric Acid and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Two-Stage NHANES Study of MASLD Prevalence and All-Cause Mortality.
BACKGROUND Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health challenge, highlighting the need for accessible markers of metabolic liver disease risk. Serum uric acid (SUA) has been linked to metabolic dysfunction, but its association with MASLD across the full clinical spectrum...